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IMPACT OF THE CUSA AND OPERATIVE
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Department of Surgery, Westmead Hospital, and The University of Sydney
(Receioed 29 August 1990)
New technologies have been developed for liver surgery, and, like all new technologies, they have a
glamour which makes them seem desirable. There is an understanding abroad that they make liver
surgery easier and open up the field to those without special training. But there is no proof that the new
devices are in any way cost-effective, and certainly no proof that liver surgery has become safer since
their advent. Fifty consecutive elective liver resections have been studied, almost half performed with
the aid of the ultrasonic dissector and aspirator and diagnostic intraoperative ultrasound. There was no
mortality in the whole group, but a 24% morbidity. Operative diagnostic ultrasound was thought to
allow more precise planning of surgery. Its use was not associated with any increase in operative time,
nor was there any increase in postoperative morbidity. The ultrasonic dissector and aspirator improved
technique, reflected in a lower blood loss for each case, in fewer transfusions required, in a shorter
postoperative hospital stay and in an ability to achieve these benefits in older patients. Neither device
could be said to offer an entree to instant liver surgery. The use of the two devices apparently offered
savings measured by a fall in the median postoperative hospital stay of 4.5 days, by a saving of 700 mls in
median blood requirement and by a fall in transfusion rate from 64% to 9%.
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INTRODUCTION
The techniques of modern hepatic surgery were defined in the early 1950’s1’2, and
have changed little since then. A recent surge of technical development has
attracted a great deal of attention. The operative ultrasound machine
3-7 appears in
more operating theatres, and surgeons have written of its diagnostic virtues. New
devices for dissecting liver parenchyma have appeared the ultrasonic aspiration
dissector (CUSA)8-11, the water jet12, the laser and the microwave coagulator
13 are
examples. New haemostatic agents including lyophilised collagen and fibrin
glue14’15 are available in some parts of the world. Reports of the use of these new
devices and materials are generally enthusiastic.
There are, however, voices of conservatism. Adson
16 has pointed out that he
operates well without these aids, and questions whether they are as attractive as
some have claimed. Questions about the long term benefits that may come from
more accurate staging of tumours with diagnostic ultrasound will not be answered
for years to come. Questions about the short term benefits, on the other hand,
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should be answerable by now, and there are already some suggestions that blood
loss is less with the CUSA10’11. The present paper offers an evaluation of the place
of operative ultrasound and of the CUSA in elective liver surgery.
MATERIALS AND METHODS
Fifty patients have been studied, having had elective hepatic resections between
January 1984 and July 1989. No selection criteria have been applied, except that the
operations were truly elective.
The principles of the operative technique were standardised. Tumours were
carefully staged by laparotomy, palpation and inspection. In the latter part of the
study, operative ultrasound was used routinely as an adjunct. The liver was
extensively mobilised, and the porta hepatis was dissected. The extent of resection
was mapped, and the porta hepatis cross clamped with a peripheral vascular clamp.
The times of clamping and release were noted. Parenchymal transection was then
undertaken with a blunt instrument. Latterly, the CUSA was used for this purpose.
The hepatic and portal vessels and ducts were displayed within the parenchyma,
and controlled with metal clips, ligatures and sutures. Gelatin foam soaked in
topical thrombin was applied to the cut surface when the resection was completed.
When any residual bleeding or bile leakage had been controlled, one or two closed
suction drains were inserted and left until their drainage volume was less than 30
mls/day. Patients were nursed for three to four days postoperatively in a high
dependency ward. Intensive care beds were not used. Parenteral or enteral
nutrition were used if indicated.
Data were maintained, using a data base written in dBase III, by JML in the
Department of Surgery at this hospital. The usual identifying details were entered.
Operation date was recorded. The level of operation was recorded as the number
of anatomic segments removed. For this purpose, segment IV was regarded as two
segments the anterior and posterior portions, or segments IVa and IVb. The
total time of portal clamping was recorded. So were operation time and total
measured blood loss. A note was also made of whether transfusion of blood was
required. It was also noted whether operative ultrasound and the CUSA were used.
Significant morbidity was defined as a postoperative complication requiring a
significant modification of treatment, radiological or surgical intervention or
prolonged stay in hospital. The following were regarded as part of the "normal"
course in hospital: fever not ascribed to a specific infective episode and not
requiring specific treatment, lung collapse responding to physiotherapy and a short
course of antibiotics, temporary hypoalbuminaemia not requiring nutritional sup-
port, a small perihepatic collection not requiring drainage. The hospital stay from
the day of operation was also calculated.
Non parametric statistical methods (Wilcoxon rank sum, chi square, Fisher’s
exact test) were used to compare the characteristics of those patients operated with
the CUSA and the operative ultrasound to those of patients operated using earlier
techniques. Multivariate techniques (multiple regression, principal component
analysis) were used to examine the determinants of morbidity and of good risk.CUSA AND OPERATIVE ULTRASOUND 273
RESULTS
General
There were 50 patients in the series, 23 men and 27 women. Their median age was
51 years (range 11-70 years). Twenty four had colonic secondaries, 7 hepatocellu-
lar carcinomas, 6 intrahepatic stones, 5 hydatids, 4 areas of focal nodular hyperpla-
sia and one each a bile duct adenoma, a cholangiocarcinoma, a cystadenoma and a
leiomyoma.
The accrual of patients has tended to increase with the passing years (Table 1),
with 6 operations performed in 1984 and 12 in the first half of 1989. Operation
levels are shown in Table 2.
Table 1
1984 6
1985 3
1986 8
1987 11
1988 10
1989 (first 6months) 12
Table 2
1 segment 10
2 segments 19
3 segments 4
4 segments 14
5 segments 1
6 segments 2
Portal clamping times
The median time of portal clamping was 15 minutes, with a range of 5 to 35
minutes.
Operation times
The median time from the start of the surgical part of the procedure to the time the
patient left the theatre was 181 minutes, with a range of 90 to 400 minutes.
Blood loss
The median blood loss was 450 mls, with a range of 100 to 4500 mls. Twenty
patients were given blood transfusion during or after operation.
Operative ultrasound
The diagnostic ultrasound was used 23 times in the 50 patients.274 J. M. LITTLE AND M. J. HOLLANDS
CUSA
The CUSA, which first became available in 1987, was used 22 times. It was not
available for all patients during the period from 1987 to 1989, so that it has been
possible to distinguish between the impact of the device and the benefits of
experience.
Differences between CUSA and non-CUSA groups
Patients in whom the CUSA was used were significantly older than those operated
before the device became available. The median age of the CUSA group was 59
years (range 24-70 years), compared to 44.5 years (range 11-69) for the non-
CUSA group. Wilcoxon testing showed this difference to be significant, p .0063.
Portal clamping times were longer in the CUSA group (median 18.5 minutes,
range 8-35 minutes), compared with 13 minutes, range 5-35 minutes (p .031,
Wilcoxon test).
Blood loss was less in the CUSA group- 275 mls (100-850 mls), compared with
950 mls (150-4500 mls) in the non-CUSA group. This difference was significant on
Wilcoxon testing, p .0039. Transfusions were less frequently used in the CUSA
group 2 of 22 patients, compared with 18 of 28 in the non-CUSA group, p
.0001, Fisher test.
The CUSA group had a shorter median hospital stay- 9.5 days (8-23 days),
compared with 14 days (9-42 days) for the non-CUSA group, p .0041, Wilcoxon
test.
No other significant differences were noted. In particular, there were no
differences in operating times nor in the incidence of major morbidity.
Influence of operative ultrasound
The use of operative ultrasound did not increase operating times. The median
operating time for the ultrasound group was 168 minutes (range 105-340 minutes),
while that for the non-ultrasound group was 185 minutes (range 90-400 minutes).
This difference was not significant (p .1103, Wilcoxon test).
Nor was there any difference in the incidence of major complications between
the two groups. Five of 23 of those in the ultrasound group suffered major
complications, compared with 8 of 27 in the non-ultrasound group (p .76, chi
square).
Independent determinants of morbidity
There were six factors which emerged as determinants of significant morbidity on
multiple regression analysis- 1. prolonged operating times, 2. higher blood loss,
3. blood transfusion, 4. female sex, 5. advancing age, and 6. not using the CUSA.
Principal components analysis suggested two factors that might determine a
straightforward postoperative course. The first was the experience of the operator
(morbidity has declined with the passing years) together with the use of the CUSA
and the operative ultrasound. The second was the use of the least possible
operation, removing the least liver and involving the shortest portal clamp times,
the shortest operating time and the least blood loss.CUSA AND OPERATIVE ULTRASOUND 275
DISCUSSION
The new technologies for liver surgery are expensive, but are they cost-effective?
When something new comes on the market, there is a quite natural feeling that
everyone should use it if they are to remain competitive. Possession of the new
becomes an essential part of continuing surgical credibility, and thoughtful evalu-
ation seems less important. This syndrome has affected the acceptance of the
CUSA and the operative ultrasound into the practice of liver surgery. Yet the
techniques of liver surgery have been well established since the early 1950’s1’2, and
it is well documented that the mortality of liver resection in the absence of cirrhosis
is less than 5% 17-19, although the morbidity remains high. The long term benefits of
resection for tumors are also clearly established17-2. In order to justify expensive
new equipment, then someone will have to demonstrate savings in cost, time or
suffering, or show that long term results are improved or that safe liver surgery is
made available to more people. It will be years before the long term survival of
those with hepatic malignancy can be reassessed, and years before we can judge
whether liver surgery has been opened up to more of those with surgically treatable
liver lesions. The present study ha3 demonstrated that significantly older patients
have been coming to surgery since the advent of operative ultrasound and the
CUSA, but there may be other explanations for this observation, including a
broadening referral base.
It will be a long time before we know whether operative ultrasound is really
helping us to stage liver cancer more accurately. What can be said so far is that the
technique is not easy to learn and that the device is not infallible in picking up small
lesions in the parenchyma. The process of adjusting gain to suit the various probes
is important, and not every imaging department can spare a technician to help
when the surgeon is working. Theatre staff must learn to maintain and adjust the
machine, as well as to care for and sterilise the probes. The learning process takes
time and patience. The present study does suggest that there are no increases in
operating times with its use, nor any associated morbidity. The lack of prolongation
of operating time is a little surprising, since it takes 10 to 15 minutes to complete the
ultrasonic examination of the liver. It is possible that the improved planning that
results from the ultrasonic information actually saves time at the next step of the
resection. It remains to be seen whether improved staging will lead to better long
term results with better patient selection for resection, and whether it becomes
possible to carry out more limited resections for tumours shown to be ultrasonically
localised. The present study has not shown any significant change in the extent of
the resections carried out before and after the availability of the ultrasound
machine.
It can equally be said that the CUSA does not make an instant liver surgeon. In
fact, the reverse is true. The ability to dissect in a controlled fashion within the
parenchyma of the liver and to perform segmental resections makes a detailed,
working knowledge of intrahepatic anatomy absolutely essential. It is easy to
disconnect segments of liver from blood supply and venous or biliary drainage
unless the surgeon knows very well what he is encountering in the depths of the
liver.
The CUSA does allow a drier operating field and excellent operating conditions.
These advantages are demonstrated by a lower blood loss among the276 J. M. LITTLE AND M. J. HOLLANDS
CUSA-treated patients and a lower transfusion rate, an important consideration in
the present era of concern about HIV and hepatitis B transmission and in the face
of periodic shortages of blood for transfusion. Multivariate analysis demonstrates
that this economy of blood usage is associated with the CUSA and not with the
operation year. It appears, therefore, to depend on the technology rather than on
increasing expertise. We have been impressed by the dryness of the field when the
resection is finished and by the relatively straightforward postoperative course
experienced by CUSA-managed patients. Their median postoperative stay in
hospital has been shorter by some 4.5 days, a saving in patient and hospital
expenses. These advantages are secured at the expense of longer portal clamp-
times. Fortunately, these have not been associated with any observable morbidity.
Total operating times have not increased.
Although both the CUSA and the operative ultrasound do seem to offer
advantages, there is no argument for making them both available in every hospital.
Surgeons manage most things that they do without their help, and both are
expensive. Both require continuing use for skills to be developed and maintained.
Both are valuable adjuncts to surgery in busy, specialised units with a major
interest in hepatic surgery. Both pieces of equipment can be shared with
neurosurgeons, urologists, cardiac and vascular surgeons, orthopaedic surgeons
and gastroenterologists, all of whom will find uses for one or both devices. Both
represent progress in surgery. Neither can substitute for basic training in anatomy,
pathology and surgical technique.
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INVITED COMMENTARY
Since its first application in liver surgery by Makuuchi and Hasegawa in Japan at
the beginning of the 80’s, intraoperative ultrasound has become increasingly widely
used in hepatic surgery centers in the West. Intraoperative ultrasound, which our
unit started using in 19841 is now routinely used in operations for both neoplastic
and benign lesions, just as cholangiography is practised in biliary surgery. As with
cholangiography, surgeons themselves are now able to carry out the investigation
and interpret the ultrasound images. A training period alongside ultrasound
specialists is indispensable and is perhaps the main drawback to wider use of this
technique. In fact the surgeon must himself perform the ultrasonography if the
operation is to be truly echo-guided and help avoid accidental damage of intrahepa-
tic structures and enable more radical tumor ablation by pinpointing a resection
line at a safe distance from the lesion. In skilled hands routine ultrasound
exploration does not lengthen operation time by more than 10 minutes.
Intraoperative ultrasound affords "real time" investigation during surgery of the
layout of the intrahepatic vessels, displaying any anatomical anomalies and showing
intrahepatic vascular involvement in neoplastic or benign diseases. It provides a
comprehensive segmental map for both normal as well as cirrhotic or otherwise
damaged livers where structures have undergone alteration on account of the mass
growth or previous operations. Moreover intraoperative ultrasound can pick up
intrahepatic lesions as small as 4-5 millimeters which would not be detected by CT
scan, angiography or preoperative ultrasound. This is because intraoperative
probes have a higher sound frequency than conventional abdominal transducers 5
or 7.5 or even 10 MHz), and therefore resolution is increased.
A prospective study was conducted in my Institution in 54 patients undergoing
surgery for primary liver tumors (32 cases) or metastases (22 cases)2. Most cases
were asymptomatic and initial diagnoses were made on the basis of a strict echo-
graphic follow-up. All patients underwent angiography, CT scan and echography
using 3.5 MHz probes. The findings were compared with the results of intraopera-
tive ultrasound (5 MHz probes), surgical exploration of the liver and the pathologi-278 J. M. LITTLE AND M. J. HOLLANDS
cal examination of the specimens in 37 patients who underwent a liver resection.
The sensitivity of intraoperative ultrasonography was 95.4% in non cirrhotic
patients and 91.1% in cirrhotics; preoperative ultrasonography had a sensibility of
84.1% and 73.5% respectively; CT scan 77.2% and 17%; angiography 65.9% and
58.8%. Intraoperative ultrasound proved of greater diagnostic value especially in
the case of minute lesions, smaller than 1 cm, which often escape pre-operative
examinations. The most rewarding results were in the cirrhotic group where a
considerable percentage of the lesions found were not palpable during laparotomy.
Another study has been carried out on the ability of intraoperative ultrasound to
detect occult synchronous liver metastases in patients with digestive tumors. 110
patients operated on for gastrointestinal or pancreatic tumors were prospectively
investigated. All patients had preoperative ultrasound and careful palpation of the
liver at surgery. Occult liver metastases were demonstrated by intraoperative
ultrasound in 8 cases; 3 patients operated for a carcinoma of the head of the
pancreas (in all cases the pancreatic resection planned was not carried out), 5 with a
rectal carcinoma and 1 with a gastric cancer. The majority of these lesions were 1
cm or less, but in 2 patients metastases were 3 and 4 cm respectively: the lesions
were hidden in the 7th segment in the "blind area" of the abdominal echographic
exploration and difficult to palpate being covered by the insertion of the triangular
ligament.
Intraoperative ultrasonography is the ultimate diagnostic examination to detect
liver tumors and as such can prompt more radical surgery where this is feasible,
while excluding patients with disseminated intrahepatic disease who would derive
no lasting benefits from surgery. The advantages of this technique are expecially
conspicuous in the case of cirrhotic livers where surgical exploration is more
difficult and parenchimal tumors often fail to be detected with palpation3.
Even if, as Little notes in his article, many colleagues have and continue to
perform brilliant liver surgery using the conventional approach, I believe, in the
light of more than 6 years experience with intraoperative ultrasound, that this
technique provides great advantages especially for more radical surgery, detecting
small non-palpable lesions, allowing for more accurate segment resections and
altogether making ablative surgery more rational by avoiding resection in cases
where intrahepatic disease is too disseminated to make surgery worthwhile.
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